跳至主要内容
临床试验/NCT02382341
NCT02382341已完成不适用

A Radiographic Study of Patients Treated With the BIOSURE™ HEALICOIL™ PK Interference Screw for ACL Repair With Soft Tissue Fixation

Smith & Nephew, Inc.0 个研究点目标入组 12 人开始时间: 2014年9月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
主要终点
Bone In-growth measured by CT scans

研究概览

简要总结

The study seeks to document the bone in-growth into the BIOSURE™ HEALICOIL PK screw as measured by CT scans. Patients' improvement in pain and function will also be followed through various outcome measures.

详细描述

The primary objective of the current study is to assess bone in-growth in the BIOSURE™ HEALICOIL™ Interference screw in the tibial tunnel of patients undergoing ACL reconstruction with soft tissue grafts; tunnel widening and change in IKDC knee and subjective scores will also be documented.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • ACL tear requiring surgical reconstruction with semitendinosus/gracilis graft.
  • Willing and able to give voluntary informed consent to participate in this study
  • Willing and able, in the opinion of the investigator, to cooperate with study procedures and willing to return to study site for all post-operative study visits.
  • Subject is between 18 and 50 years at the time of surgery
  • ASA group 0-2 (limited medical illness).

排除标准

  • Revision ACL reconstruction
  • Cartilage injury (IKDC Grade IV lesion> 2 cm2)
  • Current malignant disease
  • Rheumatoid arthritis
  • Osteonecrosis or Avascular Necrosis
  • Ankylosing spondylitis
  • Subject is Obese; BMI > 35
  • Subject is pregnant or plans to become pregnant during the study
  • Subject has received medical treatment within 6 weeks of enrollment with any of the following:
  • Glucocorticoids Growth hormone
  • Participating in another investigational trial or on-going study that would interfere with the assessment of the primary and secondary outcomes

结局指标

主要结局

Bone In-growth measured by CT scans

时间窗: 1 year

Bone In-growth measured by CT scans

次要结局

  • Improvement in IKDC Knee Examination scoring from baseline to 1 year post-operatively(1 year)
  • Bone In-growth measured by CT scans(6 months)
  • Improvement in the IKDC Subjective Knee Evaluation scoring from baseline to 1 year post-operatively(1 year)
  • Improvement in IKDC Knee Examination scoring from baseline to 2 years post-operatively(2 years)
  • Improvement in the IKDC Subjective Knee Evaluation scoring from baseline to 2 years post-operatively(2 Years)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

BIOSURE™ HEALICOIL™ PK Bone In-growth Study | 临床试验